Haiqing Luo
Affiliated Hospital of Guangdong Medical University, Department of Head and Neck Oncology, Zhanjiang, Guangdong, China · Specialty of Head and Neck Oncology, Affiliated Hospital of Guangdong Medical University · Guangdong Medical University Affiliated Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Haiqing Luo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:53 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07920250 · Pre-Radiotherapy n-6/n-3 Fatty Acid Ratio Predicts Severe Oral Mucositis in Nasopharyngeal CarcinomaAffiliated Hospital of Guangdong Medical University · completed · Nasopharyngeal Carcinoma (NPC), Radiation-induced Oral Mucositis, Head and Neck Neoplasms · principal investigator
- Ph3NCT07327216 · Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal CarcinomaAffiliated Hospital of Guangdong Medical University · recruiting · Nasopharyngeal Carcinoma (NPC) · principal investigator
- Ph2NCT07136519 · Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal CarcinomaAffiliated Hospital of Guangdong Medical University · recruiting · Nasopharyngeal Carcinoma (NPC) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:53 UTC. The ranking covers the 200 most relevant of 347 PubMed records, and a shared surname and initials can bring in a namesake. All 347 on PubMed
- Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.Nat Mater · 2017703 citationsRCR 23.2
- 689 citationsRCR 34.6
- 414 citationsRCR 25.9
- Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial.J Allergy Clin Immunol · 2020334 citationsRCR 15.3
- Real-time artificial intelligence for detection of upper gastrointestinal cancer by endoscopy: a multicentre, case-control, diagnostic study.Lancet Oncol · 2019295 citationsRCR 13.4
- Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial.J Thorac Oncol · 2022284 citationsRCR 16.2
- Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody-Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma.Clin Cancer Res · 2021256 citationsRCR 14.2
- Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer.Nat Commun · 2023224 citationsRCR 17.9
- Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer.J Immunother Cancer · 2021196 citationsRCR 9.3
- 175 citationsRCR 21.7